Filing Details
- Accession Number:
- 0001181431-10-063556
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-23 19:52:53
- Reporting Period:
- 2010-12-22
- Filing Date:
- 2010-12-23
- Accepted Time:
- 2010-12-23 19:52:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Biosciences Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376797 | B Paul Cleveland | C/O Sangamo Biosciences Inc. Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-22 | 22,037 | $2.04 | 22,037 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-12-22 | 10,000 | $4.10 | 32,037 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-22 | 22,037 | $7.00 | 10,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-12-22 | 10,000 | $7.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2010-12-22 | 22,037 | $0.00 | 22,037 | $2.04 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2010-12-22 | 10,000 | $0.00 | 10,000 | $4.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,666 | 2018-11-18 | No | 4 | M | Direct | |
| 0 | 2019-06-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on or about March 15, 2010.
- Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon the cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to each option vest in monthly installments upon completion of each month of Board service over a three year period.
- Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon the cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to each option vest in monthly installments upon completion of each month of Board service over a one year period.
Billionaire Hedge Funds
